Aclaris Therapeutics, Inc.

Aclaris Therapeutics, Inc.verified

ACRS

Price:

$2.89

Market Cap:

$206.44M

Aclaris Therapeutics, Inc. operates a clinical-stage biopharmaceutical company, develops novel drug candidates for immune-inflammatory diseases in the United States. It operates through two segments: Therapeutics and Contract Research. The Therapeutics segment is involved in identifying and developing innovative therapies to address significant unmet needs for immuno-inflammatory diseases. The Contract Research segment engages in the provision of laboratory services. The company also develops Zunsemetinib, an MK2 inhibitor for the treatment of moderate to severe rheumatoid and Psoriatic arthritis, and Hidradenitis suppurativa; and ATI-1777, a soft JAK 1/3 inhibitor for the treatment of moder...[Read more]

Industry

Medical - Diagnostics & Research

IPO Date

2015-10-06

Stock Exchange

NASDAQ

Ticker

ACRS

The Dividend Yield as of December 2024 (TTM) for Aclaris Therapeutics, Inc. (ACRS) is 0%

According to Aclaris Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Dividend Yield is 0%. This represents a change of 0% compared to the average of 0% of the last 4 quarters.

Aclaris Therapeutics, Inc. (ACRS) Historical Dividend Yield (quarterly & annually)

How has ACRS Dividend Yield performed in the past?

The mean historical Dividend Yield of Aclaris Therapeutics, Inc. over the last ten years is 0%. The current 0% Dividend Yield has changed 0% with respect to the historical average. Over the past ten years (40 quarters), ACRS's Dividend Yield was at its highest in in the December 2020 quarter at 0.01%. The Dividend Yield was at its lowest in in the December 2014 quarter at 0%.

Quarterly (TTM)
Annual

Average

0%

Median

0%

Minimum

0%

Maximum

0%

Aclaris Therapeutics, Inc. (ACRS) Dividend Yield by Quarter and Year

Discovering the peaks and valleys of Aclaris Therapeutics, Inc. Dividend Yield, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 0%

Maximum Annual Dividend Yield = 0%

Minimum Annual Increase = 0%

Minimum Annual Dividend Yield = 0%

Quarterly (TTM)
Annual
YearDividend YieldChange
20230%0%
20220%0%
20210%0%
20200%0%
20190%0%
20180%0%
20170%0%
20160%0%
20150%0%
20140%0%

Aclaris Therapeutics, Inc. (ACRS) Average Dividend Yield

How has ACRS Dividend Yield performed in the past?

The current Dividend Yield of Aclaris Therapeutics, Inc. (ACRS) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

0%

5-year avg

0%

10-year avg

0%

Aclaris Therapeutics, Inc. (ACRS) Dividend Yield vs. Peers

How is ACRS’s Dividend Yield compared to its peers?

Aclaris Therapeutics, Inc.’s Dividend Yield is less than Neogen Corporation (0%), less than Qiagen N.V. (2.94%), less than Olink Holding AB (publ) (0%), less than Syneos Health, Inc. (0%), less than Sotera Health Company (0%), less than RadNet, Inc. (0%), less than Myriad Genetics, Inc. (0%), less than Genetron Holdings Limited (0%), less than Biodesix, Inc. (0%), less than Castle Biosciences, Inc. (0%), less than Prenetics Global Limited (0%), less than IQVIA Holdings Inc. (0%), less than Medpace Holdings, Inc. (0%), less than ICON Public Limited Company (0%),

Build a custom stock screener for Aclaris Therapeutics, Inc. (ACRS) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Aclaris Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Aclaris Therapeutics, Inc. (ACRS) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Aclaris Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Dividend Yield?

How can you use the Dividend Yield?

What is Aclaris Therapeutics, Inc.'s Dividend Yield?

How is the Dividend Yield calculated for Aclaris Therapeutics, Inc. (ACRS)?

What is the highest Dividend Yield for Aclaris Therapeutics, Inc. (ACRS)?

What is the 3-year average Dividend Yield for Aclaris Therapeutics, Inc. (ACRS)?

What is the 5-year average Dividend Yield for Aclaris Therapeutics, Inc. (ACRS)?

How does the current Dividend Yield for Aclaris Therapeutics, Inc. (ACRS) compare to its historical average?